Furthermore, recent clinical studies have identified TRIM2 as a potential oncogene in human cancer cell lines including colorectal carcinoma, epithelial ovarian carcinoma and osteosarcoma [9,10,11]. Here, TRIM2 is linked to osteosarcoma.